We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers to Submit Clinical Trial Data on Failed Products Under New Proposed Rule
Drugmakers to Submit Clinical Trial Data on Failed Products Under New Proposed Rule
November 19, 2014
Drug and biologic makers would have to submit all clinical trial data to the federal government — including data for products not approved by the FDA — under a massive proposed expansion of data collection.